THC TENET HEALTHCARE CORP

NYSE tenethealth.com


$ 206.68 $ -2.13 (-1.02 %)    

Friday, 31-Oct-2025 15:59:59 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 206.49
$ 207.00
$ 206.01 x 1
$ 215.00 x 300
$ 205.65 - $ 210.47
$ 109.82 - $ 217.43
1,127,483
na
18.15B
$ 1.26
$ 13.40
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-28-2025 09-30-2025 10-Q
2 07-30-2025 06-30-2025 10-Q
3 04-29-2025 03-31-2025 10-Q
4 02-18-2025 12-31-2024 10-K
5 10-29-2024 09-30-2024 10-Q
6 07-30-2024 06-30-2024 10-Q
7 04-30-2024 03-31-2024 10-Q
8 02-16-2024 12-31-2023 10-K
9 10-30-2023 09-30-2023 10-Q
10 07-31-2023 06-30-2023 10-Q
11 04-28-2023 03-31-2023 10-Q
12 02-21-2023 12-31-2022 10-K
13 10-28-2022 09-30-2022 10-Q
14 07-29-2022 06-30-2022 10-Q
15 04-29-2022 03-31-2022 10-Q
16 02-18-2022 12-31-2021 10-K
17 10-29-2021 09-30-2021 10-Q
18 07-30-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-19-2021 12-31-2020 10-K
21 10-30-2020 09-30-2020 10-Q
22 08-03-2020 06-30-2020 10-Q
23 05-04-2020 03-31-2020 10-Q
24 02-24-2020 12-31-2019 10-K
25 11-04-2019 09-30-2019 10-Q
26 08-05-2019 06-30-2019 10-Q
27 04-29-2019 03-31-2019 10-Q
28 02-25-2019 12-31-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 08-06-2018 06-30-2018 10-Q
31 04-30-2018 03-31-2018 10-Q
32 02-26-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-01-2017 03-31-2017 10-Q
36 02-27-2017 12-31-2016 10-K
37 10-31-2016 09-30-2016 10-Q
38 08-01-2016 06-30-2016 10-Q
39 05-02-2016 03-31-2016 10-Q
40 02-22-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-maintains-outperform-on-tenet-healthcare-raises-price-target-to-252

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $23...

 ubs-maintains-buy-on-tenet-healthcare-raises-price-target-to-260

UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $238 to $260.

 cantor-fitzgerald-maintains-overweight-on-tenet-healthcare-raises-price-target-to-245

Cantor Fitzgerald analyst Sarah James maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target fr...

 guggenheim-maintains-buy-on-tenet-healthcare-raises-price-target-to-238

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $221 to ...

 nasdaq-100-hits-26000-gold-falls-below-4000-whats-moving-markets-tuesday

Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech...

 tenet-healthcare-raises-fy2025-gaap-eps-guidance-from-1405-1515-to-1466-1537-vs-1478-est

Tenet Healthcare (NYSE:THC) raises FY2025 GAAP EPS guidance from $14.05-$15.15 to $14.66-$15.37 vs $14.78 analyst estimate..

 tenet-healthcare-raises-fy2025-adj-eps-guidance-from-1555-1621-to-1593-1626-vs-1568-est-raises-fy2025-sales-guidance-from-20950b-21250b-to-21150b-21350b-vs-21133b-est

Tenet Healthcare (NYSE:THC) raises FY2025 Adj EPS guidance from $15.55-$16.21 to $15.93-$16.26 vs $15.68 analyst estimate. Rais...

 tenet-healthcare-q3-adj-eps-370-beats-330-estimate-sales-5289b-beat-5252b-estimate

Tenet Healthcare (NYSE:THC) reported quarterly earnings of $3.70 per share which beat the analyst consensus estimate of $3.30 b...

 mizuho-maintains-outperform-on-tenet-healthcare-raises-price-target-to-225

Mizuho analyst Ann Hynes maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $194 to $225.

 goldman-sachs-assumes-tenet-healthcare-at-buy-announces-price-target-of-224

Goldman Sachs analyst Scott Fidel assumes Tenet Healthcare (NYSE:THC) with a Buy rating and announces Price Target of $224.

 keybanc-maintains-overweight-on-tenet-healthcare-raises-price-target-to-225

Keybanc analyst Scott Schoenhaus maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $2...

 wells-fargo-maintains-overweight-on-tenet-healthcare-raises-price-target-to-238

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from ...

 cantor-fitzgerald-reiterates-overweight-on-tenet-healthcare-maintains-190-price-target

Cantor Fitzgerald analyst Sarah James reiterates Tenet Healthcare (NYSE:THC) with a Overweight and maintains $190 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION